Endogenous opioids mediate basal hedonic tone independent of dopamine D-1 or D-2 receptor activation. 2004

S Narayanan, and H Lam, and L Christian, and M S Levine, and D Grandy, and M Rubinstein, and N T Maidment
Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles Neuropsychiatric Institute, 760 Westwood Plaza, Los Angeles, CA 90024, USA.

Exogenously administered opiates are recognized as rewarding and the involvement of dopamine systems in mediating their apparent pleasurable effects is contentious. The aversive response to naloxone administration observed in animal studies suggests the presence of an endogenous opioid tone regulating hedonic state. We sought evidence for the requirement for dopamine systems in mediating this action of endogenous opioids by determining whether mice deficient in dopamine D-1 or D-2 receptors were able to display conditioned place aversion to naloxone. Mice received saline in the morning in one chamber and either saline or naloxone (10 mg/kg, s.c.) in the afternoon in another chamber, each day for 3 days. On the test day they were given free access to the testing chambers in the afternoon. Similar to their wild-type littermates, D-1 and D-2 receptor knockout mice receiving naloxone in the afternoon spent significantly less time on the test day in the compartment in which they previously received naloxone, compared with animals receiving saline in the afternoon. The persistence of naloxone-conditioned place aversion in D-1 and D-2 knockout mice suggests that endogenous opioid peptides maintain a basal level of positive affect that is not dependent on downstream activation of dopamine systems involving D-1 or D-2 receptors.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D003213 Conditioning, Psychological Simple form of learning involving the formation, strengthening, or weakening of an association between a stimulus and a response. Conditioning, Psychology,Psychological Conditioning,Social Learning Theory,Social Learning Theories,Theory, Social Learning
D005260 Female Females
D000339 Affect The feeling-tone accompaniment of an idea or mental representation. It is the most direct psychic derivative of instinct and the psychic representative of the various bodily changes by means of which instincts manifest themselves. Mood,Affects,Moods
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001362 Avoidance Learning A response to a cue that is instrumental in avoiding a noxious experience. Aversion Behavior,Aversion Learning,Aversive Behavior,Aversive Learning,Avoidance Behavior,Aversion Behaviors,Aversive Behaviors,Avoidance Behaviors,Behavior, Aversion,Behavior, Aversive,Behavior, Avoidance,Behaviors, Aversion,Behaviors, Aversive,Behaviors, Avoidance,Learning, Aversion,Learning, Aversive,Learning, Avoidance
D017447 Receptors, Dopamine D1 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D1-class receptor genes lack INTRONS, and the receptors stimulate ADENYLYL CYCLASES. Dopamine D1 Receptors,Dopamine-D1 Receptor,D1 Receptors, Dopamine,Dopamine D1 Receptor,Receptor, Dopamine-D1

Related Publications

S Narayanan, and H Lam, and L Christian, and M S Levine, and D Grandy, and M Rubinstein, and N T Maidment
January 1990, Psychopharmacology,
S Narayanan, and H Lam, and L Christian, and M S Levine, and D Grandy, and M Rubinstein, and N T Maidment
October 1999, European journal of pharmacology,
S Narayanan, and H Lam, and L Christian, and M S Levine, and D Grandy, and M Rubinstein, and N T Maidment
December 2021, Pain,
S Narayanan, and H Lam, and L Christian, and M S Levine, and D Grandy, and M Rubinstein, and N T Maidment
August 1988, European journal of pharmacology,
S Narayanan, and H Lam, and L Christian, and M S Levine, and D Grandy, and M Rubinstein, and N T Maidment
August 1999, Surgery,
S Narayanan, and H Lam, and L Christian, and M S Levine, and D Grandy, and M Rubinstein, and N T Maidment
January 2000, European journal of pharmacology,
S Narayanan, and H Lam, and L Christian, and M S Levine, and D Grandy, and M Rubinstein, and N T Maidment
July 1987, Journal of neurochemistry,
S Narayanan, and H Lam, and L Christian, and M S Levine, and D Grandy, and M Rubinstein, and N T Maidment
April 2006, Behavioral neuroscience,
S Narayanan, and H Lam, and L Christian, and M S Levine, and D Grandy, and M Rubinstein, and N T Maidment
July 1988, European journal of pharmacology,
S Narayanan, and H Lam, and L Christian, and M S Levine, and D Grandy, and M Rubinstein, and N T Maidment
April 1988, Neuropharmacology,
Copied contents to your clipboard!